Viewing Study NCT01324232


Ignite Creation Date: 2025-12-24 @ 9:46 PM
Ignite Modification Date: 2026-02-01 @ 7:01 AM
Study NCT ID: NCT01324232
Status: COMPLETED
Last Update Posted: 2021-11-22
First Post: 2011-03-23
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis
Sponsor: Avanir Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Central Neuropathic Pain View
None Multiple Sclerosis View
Keywords: